Enough to increase the production rate of vaccines.
The French group Sanofi announced on Wednesday January 27 an agreement with BioNTech to make its production chain available and thus help the German biotechnology company to manufacture its vaccine against Covid-19 developed with the American Pfizer and to produce more than 125 million doses in Europe.
"Sanofi and BioNTech today entered into an agreement under the terms of which Sanofi will assist BioNTech for the manufacture and supply of its anti-Covid-19 vaccine which is co-developed with Pfizer", says the French laboratory, whose own candidate vaccine with GSK is delayed in development.
[MAIN FEATURE AT 8AM] Sanofi will help Pfizer and BioNTech to produce their vaccine against Covid-19 and should package more than 100 million doses intended for the European Union by the end of 2021, announced Paul Hudson, the director general of the French laboratory #AFP 3/5 pic.twitter.com/rrAmOg5lwp
- Agence France-Presse (@afpfr) January 27, 2021
"Sanofi will give BioNTech access to its production tool and its know-how to produce more than 125 million doses of BioNTech's Covid-19 vaccine in Europe. The first batches of vaccines will be distributed by production facilities of Sanofi located in Frankfurt from summer 2021. "
With Reuters
The summary of the week
France 24 invites you to come back to the news that marked the week
I subscribe
Take international news everywhere with you!
Download the France 24 application
google-play-badge_FR